A Retrospective Study:High Intensity Focused Ultrasound (HIFU) Associated A Microbubble-enhancing Contrast (“SonoVue”) Therapy for Uterine Fibroids with Pelvic Operation History
- VernacularTitle:HIFU联合超声微泡增效剂SonoVue治疗盆腔手术史子宫肌瘤患者研究
- Author:
Hong JIANG
;
Shuang LUO
;
Min HE
;
Lian ZHANG
;
Kequan LI
;
Jia HE
- Publication Type:Journal Article
- Keywords:
HIFU;
Microbubble-enhancing contrast;
Uterine fibrodis;
Pelvic operation history
- From:
Journal of Kunming Medical University
2013;(9):58-62,88
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the feasibility of high intensity focused ultrasound (HIFU) associated microbubble-enhancing contrast (“SonoVue”) therapeutic ablation of uterine fibroids in patients with pelvic operation history. Methods A total of 100 patients with uterine fibroid from October 2010 to December 2012 in Suining Central Hospital of Sichuan were treated with HIFU associated SonoVue. Among them, 50 patients had pelvic operation history. The no-perfused volume, median fractional ablation, ablation power rate, ablation dose, treatment time and adverse reaction were recorded. Results There was no statistical significance between patients with operation history and without in no-perfused volume and ablation does. The ablation power was lower in patients with operation than without. The treatment time and room time were longer in patients with operation than without. The adverse reactions were higher in patients with operation than without, especially skin pain and lower abdominal pain ( <0.05) . According to short- and long-term follow-up results, no major complications were observed in any patients. Conclusion Pelvic operation history increases the difficulty in treatment of HIFU ablation uterine fibroids. HIFU associated contrast agent SonoVue ablation can be considered a safe and feasible approach to the management of uterine fibroids in patients with pelvic operation history after grasping the indications and contraindications.
